0000899243-22-006633.txt : 20220216
0000899243-22-006633.hdr.sgml : 20220216
20220216161038
ACCESSION NUMBER: 0000899243-22-006633
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220214
FILED AS OF DATE: 20220216
DATE AS OF CHANGE: 20220216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hwang Sooin
CENTRAL INDEX KEY: 0001862522
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39244
FILM NUMBER: 22643669
MAIL ADDRESS:
STREET 1: 260 SHERIDAN AVENUE, SUITE 400
CITY: PALO ALTO
STATE: CA
ZIP: 94306
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vincerx Pharma, Inc.
CENTRAL INDEX KEY: 0001796129
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 833197402
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 260 SHERIDAN AVENUE
STREET 2: SUITE 400
CITY: PALO ALTO
STATE: CA
ZIP: 94306
BUSINESS PHONE: 650-800-6676
MAIL ADDRESS:
STREET 1: 260 SHERIDAN AVENUE
STREET 2: SUITE 400
CITY: PALO ALTO
STATE: CA
ZIP: 94306
FORMER COMPANY:
FORMER CONFORMED NAME: Vincera Pharma, Inc.
DATE OF NAME CHANGE: 20201223
FORMER COMPANY:
FORMER CONFORMED NAME: LifeSci Acquisition Corp.
DATE OF NAME CHANGE: 20191206
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-14
0
0001796129
Vincerx Pharma, Inc.
VINC
0001862522
Hwang Sooin
260 SHERIDAN AVENUE, SUITE 400
PALO ALTO
CA
94306
0
1
0
0
Chief Business Officer
Stock Option (right to buy)
6.26
2022-02-14
4
A
0
34000
0.00
A
2032-02-13
Common Stock
34000
34000
D
Option vests over three years, with 1/3 of the shares vesting on December 23, 2022, and 1/36th of the shares vesting monthly thereafter.
By: /s/ Sooin Hwang
2022-02-16